Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that over-express ABC transporters

Figure 5

Effect of 72 h application of TTFields and chemotherapeutic agents, separately and in combination on the viability of MDA-MB-231 wild type cells and MDA-MB-231/Dox MDR cells. -â—‹- MDA-MB-231 cells treated with doxorubicin alone; - â–³ - MDA-MB-231 cells treated with doxorubicin in combination with TTFields (ref. [9]); - â–¡ - MDA-MB-231/Dox cells treated with doxorubicin alone.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us